Latest Breaking News On - Indaptus therapeutics company profile - Page 1 : comparemela.com

Indaptus Therapeutics (NASDAQ:INDP) Shares Down 10 1%

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) was down 10.1% during trading on Thursday . The stock traded as low as $2.40 and last traded at $2.48. Approximately 40,955 shares changed hands during mid-day trading, a decline of 30% from the average daily volume of 58,922 shares. The stock had previously closed at $2.76. […]

Securities exchange commissionIndaptus therapeutics incIndaptus therapeutics company profileVirtu financialIndaptus therapeuticsGet free reportFree reportIndaptus therapeutics daily

Indaptus Therapeutics, Inc (NASDAQ:INDP) Sees Large Growth in Short Interest

Indaptus Therapeutics, Inc (NASDAQ:INDP) Sees Large Growth in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Indaptus therapeutics company profileRenaissance technologiesInvestment houseIndaptus therapeutics incNorthern trust corpVanguard group incIndaptus therapeuticsGet free reportStreet corpTrust corpVanguard groupIndaptus therapeutics daily

Equities Analysts Offer Predictions for Indaptus Therapeutics, Inc s FY2023 Earnings (NASDAQ:INDP)

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Free Report) – Analysts at HC Wainwright increased their FY2023 earnings estimates for shares of Indaptus Therapeutics in a research report issued on Tuesday, November 7th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($1.90) per share for the year, up from their previous estimate of […]

Glenr andersonInvestment houseNorthern trust corpVanguard group incIndaptus therapeutics company profileRenaissance technologiesIndaptus therapeutics incIndaptus therapeuticsFree reportIndaptus therapeuticGet free reportTrust corpStreet corpIndaptus therapeutics dailyNasdaq indpEarnings estimates

Indaptus Therapeutics, Inc (NASDAQ:INDP) Short Interest Update

Indaptus Therapeutics, Inc (NASDAQ:INDP) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Glenr andersonNorthern trust corpIndaptus therapeutics company profileIndaptus therapeutics incRenaissance technologiesVanguard group incInvestment houseIndaptus therapeuticsGet free reportStreet corpIndaptus therapeutics daily

Insider Buying: Indaptus Therapeutics, Inc (NASDAQ:INDP) Major Shareholder Purchases 23,934 Shares of Stock

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) major shareholder Glen R. Anderson purchased 23,934 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The shares were purchased at an average price of $2.34 per share, for a total transaction of $56,005.56. Following the completion of the acquisition, the insider […]

Glenr andersonRenaissance technologiesInvestment houseNorthern trust corpVanguard group incIndaptus therapeutics incIndaptus therapeutics company profileIndaptus therapeuticsGet free reportStreet corpTrust corpVanguard groupIndaptus therapeutics dailyNasdaq indpInsider tradingNsider trades